Johnson & Johnson, despite its already massive scale, has impressed investors with gains over the last two years, adding roughly 40% to its market value. The company's stock has increased from around $103 at the end of 2015 to nearly $140 now. Can this growth continue?
Johnson & Johnson, despite its already massive scale, has impressed investors with gains over the last two years, adding roughly 40% to its market value. The company's stock has increased from around $103 at the end of 2015 to nearly $140 now. Can this growth continue?
Share this Article
Recommended